⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

August 26, 2025NutrientsOpen Access

RETRACTED: Gupta et al. Chickpea Peptide: A Nutraceutical Molecule Corroborating Neurodegenerative and ACE-I Inhibition. Nutrients 2022, 14, 4824

Neha Gupta Sameer Quazi Saurabh Kumar Jha Mohammad Khursheed Siddiqi Kanika Verma Swapnil Sharma Rizwan Hasan Khan Sameer S. Bhagyawant

View Full Paper

Ask AI

Bookmark

Share

Key Points

Chickpea peptide shows potential for neurodegenerative and ACE-I inhibition effects, yet findings are retracted.
Key evidence includes the initial claims of neuroprotective properties and ACE-I inhibition presented in the article.
The study was published in Nutrients, presenting initial observations of chickpea peptide effects on health.
Retraction highlights the importance of verifying claims in nutraceutical research for reliable information.

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Implication

Retraction of findings on chickpea peptide showing neurodegenerative effects and ACE-I inhibition.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Gupta et al. (2025) studied this question.

synapsesocial.com/papers/68af63e3ad7bf08b1eae43f8 https://doi.org/10.3390/nu17172754

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Retraction Note: Metabolomic profiling of amino acid alterations in anorexia nervosa: implications for appetite regulation and therapeutic strategies.2024
2Retraction Note: Evaluation of Aspergillus meal prebiotic in productive parameters, bone mineralization, and intestinal integrity in broiler chickens2024
3Retraction Note: The potential preventive role of a dietary supplement containing hydroxytyrosol in COVID-19: a multi-center study.2024
4Retraction Note: Inhibition effects of acridone on the growth of breast cancer cells in vivo.2024
5RETRACTION: Antileukotriene Therapy by Reducing Tau Phosphorylation Improves Synaptic Integrity and Cognition of P301S Transgenic Mice.Original Research · 2026

More related papers

RETRACTION: Glycogen Synthase Kinase 3β (GSK3β) Mediates 6-Hydroxydopamine-Induced Neuronal Death.2026
Retraction Note.2026
Retraction Note: Autoantibodies detection in patients affected by autoimmune retinopathies.2024

More from Nutrients

Low-Concentration Sucrose Intake During Puberty Alters Cholesterol Metabolism and Circulating Testosterone Levels in Male MiceFri,
A Scoping Review of Creatine Supplementation in Alzheimer’s Disease: Evidence from Preclinical and Clinical StudiesFri,